Abernethy, A. P., Arunachalam, A., Burke, T., McKay, C., Cao, X., Sorg, R., & Carbone, D. P. (2017). Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting. Public Library of Science (PLoS).
Chicago-стиль цитированияAbernethy, Amy P., Ashwini Arunachalam, Thomas Burke, Caroline McKay, Xiting Cao, Rachael Sorg, and David P. Carbone. Real-world First-line Treatment and Overall Survival in Non-small Cell Lung Cancer Without Known EGFR Mutations or ALK Rearrangements in US Community Oncology Setting. Public Library of Science (PLoS), 2017.
MLA-цитированиеAbernethy, Amy P., et al. Real-world First-line Treatment and Overall Survival in Non-small Cell Lung Cancer Without Known EGFR Mutations or ALK Rearrangements in US Community Oncology Setting. Public Library of Science (PLoS), 2017.